Tenofovir Abacavir Platelet Activation Study

Summary

Tenofovir Abacavir Platelet Activation Study is a clinical trial^[1].

Key Facts

• Tenofovir Abacavir Platelet Activation Study is in the country of Denmark^[2].
• Tenofovir Abacavir Platelet Activation Study's instance of is recorded as clinical trial^[3].
• Tenofovir Abacavir Platelet Activation Study's start time is recorded as +2014-01-31T00:00:00Z^[4].
• Tenofovir Abacavir Platelet Activation Study's end time is recorded as +2016-04-30T00:00:00Z^[5].
• Tenofovir Abacavir Platelet Activation Study's sponsor is recorded as Rigshospitalet^[6].
• Tenofovir Abacavir Platelet Activation Study's main subject is recorded as thromboelastography^[7].
• Tenofovir Abacavir Platelet Activation Study's number of participants is recorded as {'unit': '1', 'amount': '+43'}^[8].
• Tenofovir Abacavir Platelet Activation Study's title is recorded as Changes in Coagulation and Platelet Reactivity in HIV-1 Infected Patients Switching Between Abacavir and Tenofovir Containing Antiretroviral Regimens^[9].
• Tenofovir Abacavir Platelet Activation Study's short name is recorded as TAPAS^[10].
• Tenofovir Abacavir Platelet Activation Study's uses is recorded as partial thromboplastin time^[11].
• Tenofovir Abacavir Platelet Activation Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+35'}^[12].
• Tenofovir Abacavir Platelet Activation Study's ClinicalTrials.gov ID is recorded as NCT02093585^[13].
• Tenofovir Abacavir Platelet Activation Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[14].
• Tenofovir Abacavir Platelet Activation Study's research intervention is recorded as abacavir^[15].
• Tenofovir Abacavir Platelet Activation Study's clinical trial phase is recorded as phase IV clinical trial^[16].
• Tenofovir Abacavir Platelet Activation Study's study type is recorded as interventional study^[17].